Global Pharmaceutical Contract Manufacturing Market 2016-2020

  • Published: Nov 2016
  • Pages: 81
  • SKU: IRTNTR10393

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This market research report identifies Catalent, Lonza, and Pfizer CentreOne as the leading vendors in the global pharmaceutical contract manufacturing market. A comprehensive analysis of this market is also presented by type of contract manufacturing (API/bulk drug manufacturing and final dosage form) and by geography (Americas, APAC, and EMEA).

Global Pharmaceutical Contract Manufacturing industry overview

According to the pharmaceutical contract manufacturing market outlook, this market will witness steady growth and will post a CAGR of close to 7% during the forecast period. With the increasing number of US FDA-approved manufacturing facilities in emerging countries, the market for pharmaceutical contract manufacturing is expected to have a positive outlook over the coming years. While selecting a partner for outsourcing, pharma companies look for the US FDA-approved plants along with skilled workforce and low operating costs. For example, India has over 100 US FDA approved manufacturing facilities and is one of the most favored locations for outsourcing manufacturing services. Moreover, the implementation of WTO TRIPS-mandated product patents has led to a rise in outsourcing in the developed markets.

The advancements in medical sciences and vaccinations, along with other developments such as nanotechnology and stem cell research are expanding pharmaceutical ranges to include drugs which have a shorter shelf life, thus necessitating more composite manufacturing and distribution processes. Several pharma companies like Pfizer, CentreOne, Johnson & Johnson, and GSK are making significant investments in their R&D to introduce new medicines for different diseases. Furthermore, to cater to the growing R&D requirements of sourcing companies, CMOs are looking forward to assisting in research. Also, increasing awareness about CMOs has led to a rise in research funding and support for clinical and support services, which will further drive the demand for outsourcing in this market.

Competitive landscape and key vendors

The global pharmaceutical contract manufacturing market is highly fragmented with the major vendors accounting for the majority of market shares. The market is characterized by the presence of a large number of local, large pharmaceutical companies, and is densely distributed with suppliers.  Most of the leading international pharmaceutical companies are facing challenges in the form of price pressure, regulatory constraints, and competition from local and international pharmaceutical companies. The competitive environment in this market is expected to intensify with the increase in product extensions, technological innovations, and rise in M&A.  

 Key vendors in this market are 

  • Catalent
  • Lonza
  • Pfizer CentreOne

Other prominent vendors in the market include Abbott, Aenova, Amgen, Apotex, Aspen, AstraZeneca, Aurobindo Pharma, Baxter, BERLIN-CHEMIE, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Cipla, Coherus Biosciences, Daiichi Sankyo, Dr. Reddy's Laboratories, Eli Lilly, Emcure Pharmaceuticals, Eurofarma Laboratories, Fareva, Gedeon Richter, Gilead Sciences, GlaxoSmithKline (GSK),Hospira, Impax Laboratories, Intas Pharmaceuticals, Janssen Pharmaceuticals, Lupin, Merck, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Natco Pharma, Nexus Pharmaceuticals, Novo Nordisk, Orchid Chemicals & Pharmaceuticals, Par Pharmaceutical, Parenteral Drugs India, Patheon, Piramal, Roche Holding, Sanofi, Synthon, Teva Pharmaceuticals, Valeant Pharmaceuticals, Zentiva, Zhejiang Huahai Pharmaceutical, and Zydus Cadila.

Segmentation by type of contract manufacturing and analysis of the pharmaceutical contract manufacturing market 

  • API/bulk drug manufacturing
  • Final dosage form (FDF)

The global API/bulk drug manufacturing segment led the market during 2015 and is expected to dominate the market until the end of 2020. The sharp rise in the number of drug approvals is one of the primary factors propelling this segment’s growth. Also, biologics plays a major role in the market growth in North America as patent expiries of top-selling biologics create an opportunity for the vendors to develop cost-effective biosimilars. Thus, the expected market entry of biosimilars and generics would further strengthen the API market in this region.

Geographical segmentation and analysis of the pharmaceutical contract manufacturing market

  • Americas
  • APAC
  • EMEA

In terms of geography, the Americas was the highest revenue contributing region in the market and will continue to dominate the market during the forecast period. The growth of this market in the Americas is attributed to the increasing older population and higher uptake of biologicals. Also, the growing demand for generics and favorable initiatives taken by the governments in the pharmaceutical field and various research initiatives were taken by biotechnological companies will also drive the pharmaceutical contract manufacturing market growth in the region.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global pharmaceutical contract manufacturing market?
  • What are the key market trends impacting the growth of the global pharmaceutical contract manufacturing market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global pharmaceutical contract manufacturing market?
  • What are the market opportunities and threats faced by the vendors in the global pharmaceutical contract manufacturing market?
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the global pharmaceutical contract manufacturing market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:


Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Pharmaceutical manufacturing outsourcing

  • Increased regulatory guidelines coupled with healthcare cost containment efforts
  • Rapid innovation and reduced product development lifecycle
  • High capital investment

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Market segmentation by type of contract manufacturing

  • Global API/bulk drug contract manufacturing market
  • Global FDF market

PART 08: Geographical segmentation

  • Global pharmaceutical contract manufacturing market by geography
  • Pharmaceutical contract manufacturing market in Americas
  • Pharmaceutical contract manufacturing market in APAC
  • Pharmaceutical contract manufacturing market in EMEA

PART 09: Key leading countries

PART 10: Market drivers

  • Increased focus on core competence
  • High number of US FDA-approved manufacturing facilities in emerging countries
  • Shorter time-to-market

PART 11: Impact of drivers

PART 12: Market challenges

  • Capacity utilization issues and lack of information integration
  • Growing global competition
  • Lack of manufacturing standardization

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Consolidation through vertical integration, alliances, and acquisitions
  • Huge demand for next-generation biologics
  • Value-added services

PART 15: Vendor landscape

  • Competitive scenario

PART 16: Key vendor analysis

  • Catalent
  • Lonza
  • Pfizer CentreOne
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>